Browse Category

Investment News News 9 November 2025 - 12 November 2025

Dalal Street in Turmoil: Sensex Plunges 2,500 Points in a Week – Should You Buy the Dip or Brace for More?

Sensex Today: Benchmark Rally Extends to Day 3; Nifty Closes Above 25,850 as IT, Auto Lead—CPI Crashes to Record-Low 0.25%Indian stocks advance on global risk-on mood, upbeat domestic cues and strong stock-specific action; Groww parent surges on debut

MUMBAI | November 12, 2025 Indian equities notched a third straight advance on Wednesday, with the BSE Sensex jumping 595 points (0.71%) to 84,466.51 and the NSE Nifty 50 settling 180.85 points higher (0.70%) at 25,875.80. Gains were broad across
AB InBev (BUD) Today — Nov. 11, 2025: Morgan Stanley Trims Price Target as Buyback Progresses; DZ Bank Reiterates ‘Buy’ and Valuation Debates Heat Up

AB InBev (BUD) Today — Nov. 11, 2025: Morgan Stanley Trims Price Target as Buyback Progresses; DZ Bank Reiterates ‘Buy’ and Valuation Debates Heat Up

Updated: November 11, 2025Tickers: NYSE: BUD · Euronext Brussels: ABI Key points What changed today Morgan Stanley trims but stays bullish. In a Tuesday note, Morgan Stanley reduced its AB InBev price target to $79while maintaining Overweight. The team cut organic volume expectations
Oklo (OKLO) Nuclear Stock Skyrockets 500% on AI Data Center Hype – Bubble or Breakthrough?

Oklo Stock Falls After Wider Q3 Loss as DOE Clears Path for Fuel Facility and INL Collaboration Deepens

SANTA CLARA, Calif. — November 11, 2025. Advanced nuclear developer Oklo (NYSE: OKLO) reported a wider-than-expected third‑quarter loss after today’s closing bell, sending shares lower in late trading, even as the company announced meaningful progress on its nuclear fuel plans with the U.S.
Moderna (MRNA) Beats Q3 on Sales of New COVID Shot, Trims 2025 Outlook; Stock Whipsaws — Nov. 6, 2025

Moderna (MRNA) News Today—November 11, 2025: UBS Sees 2026 Upside, Redburn Cuts PT to $36, Bernstein Stays Market Perform After Cost Cuts

Published: November 11, 2025 Moderna, Inc. (NASDAQ: MRNA) drew multiple analyst headlines today as Wall Street recalibrated views in the wake of last week’s earnings and ongoing cost‑cutting. UBS highlighted potential 2026 upside on pipeline and expense discipline; Redburn Atlantic
Canada Goose (GOOS): Fresh 13F Moves, Buyback Launch, and New Analyst Targets — What Investors Need to Know Today (Nov. 11, 2025)

Canada Goose (GOOS): Fresh 13F Moves, Buyback Launch, and New Analyst Targets — What Investors Need to Know Today (Nov. 11, 2025)

What changed today (Nov. 11, 2025) The most recent developments as of Tuesday, Nov. 11 revolve around post‑earnings positioning and new sell‑side targets. Barclays cut its 12‑month price target to $11 while maintaining Equal‑Weight, citing a more cautious view after
Microsoft (MSFT) Stock Update & Insight Report – 2 Oct 2025

MSFT Before the Bell (Nov 10, 2025): OpenAI–AWS shockwave, Azure outlook, $9.7B IREN chips pact, dividend date, and week‑ahead catalysts

Published: Monday, November 10, 2025 — Pre‑market Quick take 1) Overnight & weekend developments investors are trading OpenAI → AWS ($38B/7yrs). OpenAI will run workloads on Amazon Web Services, diversifying away from sole reliance on Azure. The timing (announced Nov.
1 116 117 118 119 120 131
Go toTop